Pharmasum Therapeutics
PrivateLast Round
Crowdfunding
Jun 28, 2023
Total Funding Raised
$3.27M
Company Overview
Pharmasum Therapeutics operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Crowdfunding round in June 2023.
Pharmasum Therapeutics is a biotechnology company focused on the discovery and development of novel human medicines for the treatment of neurological, autoimmune, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmasum Therapeutics Comparables
Compare Pharmasum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perha Pharmaceuticals | 87% | |
| T3D Therapeutics, Inc. | 77% | |
| AgeneBio, Inc. | 72% |
For institutional investors. Book with your work email.
Pharmasum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 28, 2023 | ||||
| Grant | Feb 5, 2015 |
For institutional investors. Book with your work email.
Pharmasum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovasjon Norge | Grant |
| Folkeinvest | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 27, 2024
Grew 200% QoQ from 2 to 6 employees.
- Sep 13, 2024
Grew 500% QoQ from 1 to 6 employees.
For institutional investors. Book with your work email.
Pharmasum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pharmasum Therapeutics's valuation, stock price, and market status.
Is Pharmasum Therapeutics a public or private company?
Pharmasum Therapeutics is a private company.
What is the current stock price of Pharmasum Therapeutics?
Pharmasum Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pharmasum Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharmasum Therapeutics worth (valuation)?
Valuation information for Pharmasum Therapeutics is not publicly available.
Can I buy Pharmasum Therapeutics stock?
Pharmasum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharmasum Therapeutics's last funding round?
Pharmasum Therapeutics's most recent funding round was Crowdfunding on June 28, 2023.
Who are the main investors in Pharmasum Therapeutics?
Key investors in Pharmasum Therapeutics include Innovasjon Norge, Folkeinvest.
Will Pharmasum Therapeutics IPO soon?
No public IPO plans have been announced for Pharmasum Therapeutics.
How can I track Pharmasum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pharmasum Therapeutics's shares on secondary markets.